Stock UniverseDerived research view · source repositories remain read-only

Amneal Pharmaceuticals, Inc. (AMRX)

Therapeutics / Biopharma · Healthcare / Drug Manufacturers - Specialty & Generic
Score Band
Watch
Selection Score
33.37
Global Rank
1508
Market Cap
4.34B
Latest Close
13.75
RS Composite
1.70% · G#1223

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
0.95%
3M
3.85%
6M
12.89%
1Y
90.71%
3Y
487.61%
5Y
142.93%
10Y
-8.39%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 1.25M · 30-day average: 1.58M · Max drawdown over stored range: -94.77%

Research Snapshot

Relative Strength vs SPX

RS Composite1.70%
20D RS-0.42%
60D RS-0.79%
120D RS5.25%
Global RS Rank1223 · 63.55% percentile
Watch+Speculative RS Rank787 · 62.47% percentile
Group ScopeWatch+Speculative
Primary RS Rank124 · 72.93% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank194 / 701
Primary Percentile72.47
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-05-073.05B1.18B435.52M122.12M0.37404.48M114.23M290.25M326M38.66%14.30%4.01%13.28%9.53%197.66M2.57B

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$0.3736.7x$9.341.5x$0.8915.4x$1.2411.1x

Shares Diluted: 326M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue1992.5232093.6692212.3042393.6072793.9573018.76
Revenue Growth (YoY)22.513%5.076%5.666%8.195%16.726%8.046%
Gross Profit652.317783.949791.461863.8691015.5131128.46
Operating Income145.66216.598200.033271.382348.363420.698
Free Cash Flow317.165190.88116.305298.776234.759241.149
Free Cash Flow Per Share2.131.2570.1081.6960.760.742
EPS (Diluted) GAAP0.610.07-0.861153-0.476864-0.3782980.22
EPS Growth6900%-88.525%6900%6900%6900%
EPS Non-GAAP
Gross Margin32.738%37.444%35.775%36.091%36.347%37.382%
Operating Margin7.31%10.345%9.042%11.338%12.468%13.936%
Profit Margin4.57%0.507%-5.876%-3.509%-4.184%2.387%
Free Cash Flow Margin15.918%9.117%0.737%12.482%8.402%7.988%
Shares Outstanding (Diluted)148.913151.821150.944176.136308.978324.805
Shares Change (YoY)12.722%1.953%-0.578%16.69%75.42%5.122%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-07722.52M44.31%141.77M19.62%62.26M8.62%0.19328.93M197.66M2.57Bprocessed
2025 Q42026-02-27814.32M36.50%112.03M13.76%35.08M4.31%0.11328.11M282.03M2.57Bprocessed
2025 Q32025-11-06784.51M34.92%70.34M8.97%2.37M0.30%0.01324.75M201.25M2.57Bprocessed
2025 Q22025-08-07724.51M39.51%111.37M15.37%22.42M3.09%0.07322.36M71.54M2.15Bprocessed
2025 Q12025-05-07695.42M36.80%100.35M14.43%12.20M1.75%0.04323.96M59.19M2.15Bprocessed
2024 Q42025-02-28730.52M35.98%75.79M10.38%n/an/an/a309.86M110.55M2.16Bprocessed
2024 Q32024-11-12702.47M38.37%88.81M12.64%-156.00K-0.02%0.06309.65M74.01M2.17Bprocessed
2024 Q22024-08-09701.78M35.62%95.47M13.60%5.99M0.85%0.02318.96M43.77M2.18Bprocessed
2024 Q12024-05-08659.19M36.11%-10.75M-1.63%-91.64M-13.90%-0.30307.28M46.52M2.38Bprocessed
2023 Q42024-03-14616.98M30.77%14.19M2.30%-101.41M-16.44%-0.43235.69M91.54M2.39Bprocessed
2023 Q32023-11-09620.04M37.50%75.65M12.20%15.54M2.51%0.06159.69M86.93M2.54Bprocessed
2023 Q22023-08-08599.05M36.73%80.08M13.37%22.23M3.71%0.08154.89M109.28M2.55Bprocessed
2023 Q12023-05-09557.54M31.96%34.45M6.18%-15.63M-2.80%-0.05152.11M144.67M2.56Bprocessed
2022 Q42023-03-03609.76M35.32%36.03M5.91%-12.03M-1.97%-0.08151.48M25.98M2.59Bprocessed
2022 Q32022-11-07545.56M35.60%44.35M8.13%-7.61M-1.40%-0.02151.39M87.33M2.61Bprocessed
2022 Q22022-08-08559.36M35.85%-198.62M-35.51%-242.13M-43.29%-0.80150.99M91.98M2.62Bprocessed
2022 Q12022-05-06497.63M35.08%23.30M4.68%-8.82M-1.77%-0.01149.89M210.48M2.67Bprocessed
2021 Q42022-03-01536.90M30.99%11.18M2.08%-21.80M-4.06%-0.14152.32M247.79M2.68Bprocessed
2021 Q32021-11-08528.59M37.55%28.52M5.39%-7.78M-1.47%-0.03149.29M302.65M2.69Bprocessed
2021 Q22021-08-09535.08M39.71%67.12M12.54%29.99M5.61%0.10151.99M278.31M2.72Bprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.